Jump to:Page Content
Stand out from the crowd! Advertise in Trial to reach a national audience of major decision-makers who are looking for products and services to improve their legal practices.
Allison Torres Burtka
Two recent studies examining the agency’s premarket approval (PMA) process faulted the FDA for relying on insufficient and potentially biased data to approve heart devices between 2000 and 2007. Many PMA applications were supported by a single study, the researchers found.